Medical Linear Particle Accelerator - Market Insights, Competitive Landscape, and Market Forecast - 2030

Global medical linear particle accelerator market was valued at USD 2.56 billion in 2023, growing at a CAGR of 4.79% during the forecast period from 2024 to 2030 to reach USD 3.39 billion by 2030. The increase in demand for medical linear particle accelerator is primarily attributed to the increasing prevalence of cancer due to increased exposure to chemical and carcinogenic substances, age, unhealthy eating habits, processed or packed food, environmental pollutants, tobacco, alcohol, certain medications, radiations, and others. Moreover, the increasing demand of radiotherapy devices worldwide will drive the market of medical linear particle accelerator in the forthcoming years. Additionally, technological advancements in product such as optimization of beam lines and access to create real-time simulations of the device and the increased research and developmental activities in relation to cancers across the world are anticipated to bolster the market, thereby contributing to the growth of the medical linear particle accelerator market during the forecast period from 2024-2030.

Medical Linear Particle Accelerator Market Dynamics:

The medical linear particle accelerator market is witnessing a growth in product demand owing to various reasons.

The increasing prevalence of cancer such as, lung cancer, prostate cancer, and others worldwide due to various factors such as, genetic, age, obesity, unhealthy lifestyles, processed or packed food, environmental pollutants, tobacco, alcohol, certain medications, radiations, and others and increasing number of geriatric patients prone to cancer across the world are anticipated to bolster the market. For instance, according to the data published by World Health Organization (WHO) in 2022, it was estimated that in the year 2020 cancer caused nearly 10 million deaths globally. As per the same source, in the year 2020, globally the most common new cases of cancer were of breast (2.26 million cases), lung (2.21 million cases), colon and rectum (1.93 million cases), prostate (1.41 million cases), skin (non-melanoma1.20 million cases), and stomach (1.09 million cases). From the above statistics, it can be established that the prevalence of cancer is increasing globally. The increasing prevalence of cancer will increase the demand of medical linear accelerators as the device is used to omit radiations to cure the tumor in the body. Therefore, the above factor is anticipated to increase the demand of medical linear accelerators in the market, thereby leading to overall market growth of the device in the forecast period of 2022 - 2028.

Moreover, the escalating burden of geriatric population globally will propel the market growth of the device. For instance, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030 globally. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The people that are aged 80 years or older is expected to triple between 2020 and 2050 and is expected to reach 426 million. Thus, the number of geriatric population is increasing which will in turn affect the prevalence of cancer patients as age is one of the major risk factor for cancer. The increased prevalence of cancer will bolster the market of medical linear particle accelerator in the forecast period.

Furthermore, the increasing adoption of radiotherapy pertaining to the cure of cancer will account for the unprecedented growth of the medical linear particle accelerator worldwide.

Thus, due to the increasing prevalence of cancer globally, surging geriatric population, and an increasing demand of radiotherapy devices, there will be a rising demand for medical linear particle accelerator, in turn increasing the medical linear particle accelerator market growth.

However, the high cost of the devices, lack of skilled and experienced personnel in the under developed or developing companies, and the stringent regulatory approval process may pose as a challenge to the medical linear particle accelerator market growth.

The ongoing COVID-19 pandemic has negatively impacted the market for medical linear particle accelerator as elective surgeries were not performed for some time. The admission and treatment of COVID-19 patients were priority as compared to other disorders. Moreover, there were disruption in the supply chain leading to unavailability of raw materials halting the manufacturing process. This lead to increase in shortage of devices in the market hampering the overall market growth. Moreover, while the onset of the pandemic, the research & developmental activities were stopped, hampering the market of the device. But, with return of normalcy and masses being vaccinated, the market has again picked up the momentum.

Medical Linear Particle Accelerator Market Segment Analysis:

Medical linear particle accelerator market by Product Type (Dedicated Linear Accelerator and Non-Dedicated Linear Accelerator), by Treatment Type (Intensity Modulated Radiation Therapy, Volumetric Modulated Arc Therapy, Image Guided Radiation Therapy, and Stereotactic Radiosurgery/Stereotactic Body Radiotherapy), by Application Type (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancers, Colorectal Cancers, and Others), by End User (Hospital, Radiology Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application type segment of the medical linear particle accelerator market, the lung cancer is estimated to hold a significant share in the medical linear particle accelerator market in the year 2023. This can be ascribed to the wide application circle that is associated with the category.

For instance, according to the Centers of Disease Prevention and Control (CDC) 2022, the data stated that the lung cancer is the third most common cancer in the United States. In the year 2019, in the United States, 221,097 new cases of Lung and Bronchus cancer were reported, and 139,601 people died of this cancer. Moreover, as per the National Cancer Institute, Cancer Stat Facts: Lung and Bronchus Cancer, it was stated that an estimated 236,740 people will be diagnosed with lung cancer in 2022 in the U.S. Furthermore, the lung cancer mainly occurs in older people. Most people diagnosed with lung cancer are 65 or older; a very small number of people diagnosed are younger than 46 years of age. The increasing prevalence of lung cancer across the globe will bolster the market growth of the lung cancer in the application segment.

Thus, owing to the increasing prevalence of lung cancer, there will be an increase in the demand for devices for lung cancer, which in turn will drive the medical linear particle accelerator market growth.

North America is expected to dominate the overall Medical Linear Particle Accelerator Market:

Among all the regions, North America is expected to account for the significant share in the global medical linear particle accelerator market. The growing incidence of cancer due to high consumption of processed food & lifestyle changes, growing incidence of obesity, increasing number of geriatric population susceptible to cancer, increasing demand of radiotherapy devices across the region will be responsible for increased demand of the market of medical linear particle accelerator in North America, leading to a rise in the overall medical linear particle accelerator market growth.

For instance, according to the CDC 2022, it was estimated that in the year 2019, in the United States, 264,121 new cases of female breast cancer were reported among women, and 42,280 women died of this cancer. Further, as per the data stated by the American Cancer Society 2022, it is estimated that about 287,850 new cases of invasive breast cancer will be diagnosed in women in the United States for the year 2022. The statistics states that the incidence of breast cancer is increasing in the United States, ultimately asking for the increased demand of medical linear particle accelerator in the market. Thus, the increasing prevalence of breast cancer will increase the demand of the medical linear particle accelerator, thereby anticipated to boost the overall market growth of the device in the North America in the study period of 2022- 2028.

Furthermore, unhealthy life is contributing for an increase in the prevalence of various cancers in the region. Adults who eat a healthy diet live longer, have a lower risk of obesity, heart disease, type 2 diabetes, and certain cancers. Most Americans, however, do not follow a healthy lifestyle. As per Centers for Disease Control and Prevention (CDC), 2022, fewer than 1 in 10 adults and adolescents eat enough fruits and vegetables, and 9 in 10 Americans aged 20 years or older consume more than the recommended amount of sodium. The unhealthy lifestyle will increase the prevalence of cancers in the forecast period. The device is used in the treatment of cancers leading to increased demand of medical linear particle accelerator in the North America market.

Another factor responsible for increasing the product demand is the technological advancements in the medical device. Various features such as the incorporation of artificial intelligence, optimization of beam lines and access to create real-time simulations of the device will increase the demand of the medical linear particle accelerator in North America. All the features are making the devices more and more convenient and easy to use, thereby bolstering the market.

Thus, all the above-mentioned factors are anticipated to propel the market for medical linear particle accelerator in the North America.

Medical Linear Particle Accelerator Market Key Players:

Some of the key market players operating in the medical linear particle accelerator market include Varian Medical Systems, Inc., Elekta, Accuray Incorporated, Shinva Medical Instrument Co., Ltd., Viewray Technologies, INC., Altair Technologies, Inc., AccSys Technology, Inc., S.I.T. Sordina IORT Technologies S.p.A., Siemens Healthcare GmbH, Brainlab AG, Panacea Medical Technologies Pvt. Ltd., MITSUBISHI HEAVY INDUSTRIES, LTD., among others.

Recent Developmental Activities in the Medical Linear Particle Accelerator Market:

• In October 2022, Panacea Medical Technologies, one of the world-leading manufacturer of advanced Radiation Oncology and Radiology equipment, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its next generation Stereotactic Body Radiotherapy (SBRT) enabled Linear Accelerator on a ring gantry platform. The system can deliver sophisticated treatment for various cancer cases in record time thereby increasing patient throughput for the clinics.
• In April 2022, Varian, a Siemens Healthineers company, built and delivered innovative cancer care technologies and solutions, had signed an agreement with Australia’s Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further strengthens the global partnership between Varian and Icon Group, together increasing access to care across regional and underserviced areas in Australia and Asia.

Key Takeaways from the Medical Linear Particle Accelerator Market Report Study

• Market size analysis for current medical linear particle accelerator market size (2023), and market forecast for 6 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the medical linear particle accelerator market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global medical linear particle accelerator market.
• Various opportunities available for the other competitor in the medical linear particle accelerator market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current medical linear particle accelerator market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for medical linear particle accelerator market growth in the coming future?

Target Audience who can be benefited from this Medical Linear Particle Accelerator Market Report Study

• Medical linear particle accelerator products providers
• Research organizations and consulting companies
• Medical linear particle accelerator-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in medical linear particle accelerator
• Various End-users who want to know more about the medical linear particle accelerator market and latest technological developments in the medical linear particle accelerator market.

Frequently Asked Questions for Medical Linear Particle Accelerator Market:

1. What are medical linear particle accelerator?

A medical linear particle accelerator, is a medical device, which delivers high-energy x-rays or electrons. The x-rays or electrons are used to conform to a tumour’s shape and destroy cancer cells while sparing surrounding normal tissue. The device is most commonly used for external beam radiation treatments for patients with cancer.

2. What is the market for Global medical linear particle accelerator?

Global medical linear particle accelerator market was valued at USD 2.56 billion in 2023, growing at a CAGR of 4.79% during the forecast period from 2024 to 2030 to reach USD 3.39 billion by 2030.

3. What are the drivers for the Global medical linear particle accelerator market?

The medical linear particle accelerator market is witnessing a positive market growth owing to the increasing prevalence of cancer globally and the increasing adaption of radiotherapy devices. Additionally, technological advancements in product such as optimized beam lines and to create real-time simulations across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global medical linear particle accelerator market?

Some of the key market players operating in the medical linear particle accelerator market include Varian Medical Systems, Inc., Elekta, Accuray Incorporated, SHINVA MEDICAL INSTRUMENT CO., LTD., VIEWRAY TECHNOLOGIES, INC., Altair Technologies, Inc., AccSys Technology, Inc., S.I.T. Sordina IORT Technologies S.p.A., Siemens Healthcare GmbH, Brainlab AG, Panacea Medical Technologies Pvt. Ltd., MITSUBISHI HEAVY INDUSTRIES, LTD., and others.

5. Which region has the highest share in medical linear particle accelerator market?

North America is expected to hold the highest share in the revenue in the medical linear particle accelerator market during the forecast period. High prevalence of cancer in the region and increasing adaption of radiotherapy devices will propel the medical linear particle accelerator in the North America, leading to a rise in the overall medical linear particle accelerator market growth in this region.


This product will be delivered within 2 business days.